These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16296788)

  • 21. Synergic enhancing-effect of DEET and dodecylamine on the skin permeation of testosterone from a matrix-type transdermal delivery system.
    Zhao H; Choi MK; Kim JS; Yong CS; Choi HG; Chung SJ; Shim CK; Kim DD
    Drug Deliv; 2009 Jul; 16(5):249-53. PubMed ID: 19538005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, development, physicochemical, in vitro and in vivo evaluation of monolithic matrix type transdermal patches containing nitrendipine.
    Mittal A; Sara US; Ali A; Mohammed A
    Pharm Dev Technol; 2009; 14(4):422-34. PubMed ID: 19630699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and in vivo evaluation of an indapamide transdermal patch.
    Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
    Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced transdermal delivery of loratadine from the EVA matrix.
    Cho CW; Choi JS; Kim SJ; Shin SC
    Drug Deliv; 2009 May; 16(4):230-5. PubMed ID: 19514983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of transdermal and oral oxybutynin in children with neurogenic detrusor overactivity.
    Cartwright PC; Coplen DE; Kogan BA; Volinn W; Finan E; Hoel G
    J Urol; 2009 Oct; 182(4):1548-54. PubMed ID: 19683731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skin permeation of ketotifen applied from stick-type formulation.
    Kimura C; Nakanishi T; Tojo K
    Eur J Pharm Biopharm; 2007 Sep; 67(2):420-4. PubMed ID: 17433642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
    Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T
    J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transdermal drug delivery systems: skin perturbation devices.
    Brown MB; Traynor MJ; Martin GP; Akomeah FK
    Methods Mol Biol; 2008; 437():119-39. PubMed ID: 18369965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transdermal androgens: pharmacology and applicability to hypogonadal elderly men.
    Swerdloff RS; Wang C
    J Endocrinol Invest; 2005; 28(3 Suppl):112-6. PubMed ID: 16042369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transdermal delivery of oxybutynin chloride proniosomal gels for the treatment of overactive bladder.
    Rajabalaya R; David SR; Chellian J; Xin Yun G; Chakravarthi S
    Drug Deliv; 2016 Jun; 23(5):1578-87. PubMed ID: 26634274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute.
    Wokovich AM; Prodduturi S; Doub WH; Hussain AS; Buhse LF
    Eur J Pharm Biopharm; 2006 Aug; 64(1):1-8. PubMed ID: 16797171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transdermal permeation of trimetazidine from nerodilol-based HPMC gel drug reservoir system across rat epidermis.
    Krishnaiah YS; Al-Saidan SM
    Med Princ Pract; 2008; 17(1):37-42. PubMed ID: 18059099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testosterone treatment comes of age: new options for hypogonadal men.
    Nieschlag E
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):275-81. PubMed ID: 16918944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models.
    Godin B; Touitou E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1152-61. PubMed ID: 17889400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microprocessor-controlled iontophoretic drug delivery of 5-fluorouracil: pharmacodynamic and pharmacokinetic study.
    Chandrashekar NS; Shobha Rani RH
    J BUON; 2007; 12(4):529-34. PubMed ID: 18067212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of ibuprofen gel formulations using experimental design technique for enhanced transdermal penetration.
    Rhee YS; Chang SY; Park CW; Chi SC; Park ES
    Int J Pharm; 2008 Nov; 364(1):14-20. PubMed ID: 18755258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function.
    Chiang HS; Hwang TI; Hsui YS; Lin YC; Chen HE; Chen GC; Liao CH
    Int J Impot Res; 2007; 19(4):411-7. PubMed ID: 17538639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced transdermal delivery of a dipeptide by dermaportation.
    Namjoshi S; Chen Y; Edwards J; Benson HA
    Biopolymers; 2008; 90(5):655-62. PubMed ID: 18536044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microneedle-based drug delivery: studies on delivery parameters and biocompatibility.
    Wu Y; Qiu Y; Zhang S; Qin G; Gao Y
    Biomed Microdevices; 2008 Oct; 10(5):601-10. PubMed ID: 18324474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of isothermal heat conduction microcalorimetry, X-ray diffraction, and optical microscopy for characterisation of crystals grown in steroid combination-containing transdermal drug delivery systems.
    Latsch S; Selzer T; Fink L; Horstmann M; Kreuter J
    Eur J Pharm Biopharm; 2004 Mar; 57(2):397-410. PubMed ID: 15019001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.